Event logo
Hero banner

Biology Webinar | Human-Relevant Biology and NAMs: Advancing the 3Rs.

14 December 2026
14:00 (CET)
Online

Welcome from
the chair

11th Biology Webinar
Human-Relevant Biology and NAMs: Advancing the 3Rs

I am delighted to invite you to this webinar on “Human-Relevant Biology and NAMs: Advancing the 3Rs.”. As science moves towards more predictive, human-relevant models, NAMs are reshaping how we replace, reduce and refine animal use in research. Our expert speakers will share practical insights, real-world applications and the opportunities ahead. Whether you work in academia, the industry or regulation, I hope you will join us for an inspiring discussion and leave with ideas to apply to your own work.

We are honoured to welcome three distinguished speakers:

  • Dr Margaret Magdesian is a Scientist–Entrepreneur and the Founder of Ananda Devices. Dr Magdesian pioneered nervous-system-on-a-chip technology enabling accelerated, predictive testing using human neuronal and neuromuscular models.
  • Dr Sasha Berdichevski is a Biomedical Scientist and the Founder of SciBer Ltd, who drives new approach methodologies and organ-on-a-chip adoption globally, building on her leadership at Emulate, Inc., and her PhD at Technion University in imaging host responses and engineering regenerative micro-carriers.
  • Dr Karthik Mohanraj is a Principal Scientist at Magnitude Biosciences Ltd, a UK-based CRO specialising in utilising Caenorhabditis elegans for drug discovery and healthy ageing research.

We warmly invite researchers, industry professionals, students, and anyone interested in new approach methodologies to join us for this dynamic and informative session. We look forward to seeing you there.

Date: 14 December 2026
Time: 14:00 CET | 8:00 EST
Webinar ID: Webinar ID
846 4533 7938



Meet Our Chair

Explore more chairs
Dr. Julia Mantaj

School of Applied and Health Sciences, London South Bank University, London SE1 0AA, UK;Dr Julia Mantaj graduated as a Pharmacist from the Technical University of Braunschweig, Germany, then completed a PhD at King’s College London (KCL), where she studied DNA minor-groove binding agents and their effects on gene expression. She then spent two years in the industry as a Postdoctoral Researcher developing next-generation DNA-interactive payload molecules for antibody–drug conjugates. In 2018, she returned to KCL as a Research Associate, contributing to the design of non-invasive drug delivery systems, and later became a Teaching Fellow in Pharmacy in 2019. Dr Mantaj joined London South Bank University in September 2024 as a Senior Lecturer in Pharmaceutical Science. Her current research focuses on developing human-derived organoid models to enhance in vitro physiological studies and creating hydrogel-based systems for rectal delivery of cell therapies to treat inflammatory bowel disease (IBD).

Registration Information

This is a FREE webinar. After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Certificates of attendance will be delivered to those who attend the live webinar.

Can't attend? Register anyways and we'll let you know when the recording is available to watch.

Register for free here!

Meet Our Speakers

Explore more speakers
Dr. Margaret Magdesian

Dr. Margaret Magdesian

ANANDA Device, Laval, Canada;Margaret Magdesian, PhD | Founder & CSO Dr. Magdesian is a Scientist–Entrepreneur with more than 30 years of experience in biopharmaceutical research and human-relevant model development. In collaboration with researchers at McGill University, she pioneered nervous-system-on-a-chip technology enabling accelerated, predictive testing using human neuronal and neuromuscular models. She founded Ananda Devices in 2015 to translate this innovation into scalable platforms for drug discovery and toxicity testing. As the CSO, Dr. Magdesian leads the company's scientific vision, innovation strategy, and partnerships, advancing human-relevant testing as a new standard for the industry.

Dr. Sasha Berdichevski

Dr. Sasha Berdichevski

SciBer Ltd., Cambridge, United Kingdom;Dr. Sasha Berdichevski is a Biomedical Scientist and the Founder of SciBer Ltd, dedicated to driving the development and global adoption of new approach methodologies (NAMs). She currently serves as Mepsgen’s Head of Innovation and Business Development for Europe, where she leads the integration of organ-on-a-chip and nanoparticle synthesis technologies into drug development and translational research. Previously, she was the Principal Team Lead at Emulate, Inc., where she managed customer relationships, global partnerships and programmes for the validation and adoption of organ-on-chip platforms across academia, the industry and regulatory sectors. She earned a PhD at the Technion, Israel, where she developed imaging methodologies to study host responses to biodegradable implants and designed injectable micro-carriers for cardiac muscle regeneration. Her PhD at the University of Cambridge and at AstraZeneca focused on investigating the effects of microenvironment on 3D in vitro tissue formation and function.

Dr. Karthik  Mohanraj

Dr. Karthik Mohanraj

Magnitude Biosciences Ltd , Sedgefield, United Kingdom;Dr Karthik Mohanraj is a Principal Scientist at Magnitude Biosciences Ltd, a UK-based CRO specialising in utilising Caenorhabditis elegans for drug discovery and healthy ageing research. With over 15 years of experience in cell and molecular biology, and expertise in mitochondrial biology, his work focuses on developing and applying innovative in vivo assays to investigate healthspan, longevity and disease-related processes. At Magnitude Biosciences, he contributes to the development and application of high-throughput screening and automated healthspan platforms, including WormGazer™ and VivoScan™, supporting early-stage drug discovery and the advancement of new approach methodologies (NAMs) aligned with the 3Rs principles.

Sponsors and Partners

Sponsors


MDPIBiology

Powered by Sciforum
Disclaimer
Terms and ConditionsPrivacy PolicyAccessibility